Clinical Trial

Esketamine Combined With PRF of DRG for Postherpetic Neuralgia

Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated April 9, 2025 (before its estimated July 1, 2026 completion). Its status may not reflect the trial's current state.
Summary
This trial's primary objective is to compare the analgesic efficacy of esketamine in combination with pulsed radiofrequency (PRF) of dorsal root ganglion(DRG) against that of PRF monotherapy in patients with postherpetic neuralgia(PHN).
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-03-31.
Trial Details
NCT Number NCT06914193
Lead Sponsor Beijing Tiantan Hospital
Collaborators: Beijing Xiaotangshan Hospital, The First Hospital of Fangshan District,Beijing, Beijing Ditan Hospital, Hengshui People's Hospital
Conditions Postherpetic Neuralgia
Enrollment 186 participants
Start Date 2025-04-01
Primary Completion 2026-07-01 (estimated)
Study Completion 2026-10-01 (estimated)
Updated on ClinicalTrials.gov 2025-04-09